# Retension Pharmaceuticals Inc. (RTSN)

Source: https://www.quantisnow.com/company/RTSN
Generated: 2026-11-15T18:46:58.705Z

- Ticker: RTSN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2026
- SEC CIK: 0002002988

## About

Retension Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. The Company's lead clinical candidate, RTN-001, is in development for patients with uncontrolled and resistant hypertension.

## Latest RTSN news and filings

- 2026-11-05 13:02 UTC [Conference Announcement] [Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference](https://www.quantisnow.com/insight/retension-pharmaceuticals-to-participate-in-the-guggenheim-3rd-annual-healthcare-6774894)
- 2026-11-04 21:31 UTC [SEC Form 4] [VP, Chief Accounting Officer Wong Robert was granted 25,000 stock options (SEC Form 4)](https://www.quantisnow.com/insight/vp-chief-accounting-officer-wong-robert-was-granted-25000-stock-6773154)
- 2026-11-04 21:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Wong Robert](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-wong-robert-6773109)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RTSN
- Earnings history: https://www.quantisnow.com/earnings/RTSN
- Dividend history: https://www.quantisnow.com/dividends/RTSN
- Insider transactions: https://www.quantisnow.com/insiders/RTSN
- Options chain: https://www.quantisnow.com/options/RTSN
- SEC 8-K filings only: https://www.quantisnow.com/company/RTSN/8-k
- RSS and alerts for RTSN: https://www.quantisnow.com/docs/rss-feeds.md